Sriram Amirneni

Also affiliated with Institute for Transfusion Medicine

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Is HSD17B13 Genetic Variant a Protector for Liver Dysfunction? Future Perspective as a Potential Therapeutic Target”.

Is HSD17B13 Genetic Variant a Protector for Liver Dysfunction? Future Perspective as a Potential Therapeutic Target

Journal of Personalized Medicine(2021)10.3390/jpm11070619

N/A

0DataRank · unranked

22 citations

Sriram Amirneni, Ricardo Díaz‐Aragon, Lanuza A.P. Faccioli, Michelle R. Malizio, Michael C. Coard +7 more

Human Hepatocytes Isolated from Explanted Livers: A Powerful Tool to Understand End-stage Liver Disease and Drug Screening

Organogenesis(2021)10.1080/15476278.2021.1992216

N/A

0DataRank · unranked

2 citations

Zehra N. Kocas‐Kilicarslan, Ricardo Díaz‐Aragon, Takashi Motomura, Sriram Amirneni, Michelle R. Malizio +6 more

Polymorphisms Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease Influence the Progression of End-Stage Liver Disease

Gastro Hep Advances(2023)10.1016/j.gastha.2023.09.011

N/A

0DataRank · unranked

14 citations

Zeliha Cetin, Lanuza A.P. Faccioli, Takashi Motomura, Sriram Amirneni, Ricardo Díaz‐Aragon +16 more